Head and neck cancer drug combo study halted early
NCT ID NCT04854499
First seen Nov 19, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study tested a new drug called magrolimab combined with other cancer treatments for people with head and neck squamous cell carcinoma that had spread or come back. The goal was to see if the combination was safe and effective. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST degli Spedali Civili di Brescia
Brescia, 25123, Italy
-
AZ Sint-Maarten
Mechelen, 2800, Belgium
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Algemeen Ziekenhuis Klina
Brasschaat, 2930, Belgium
-
Arcispedale Santa Maria Nuova
Reggio Emilia, 42100, Italy
-
Astera Cancer Care
East Brunswick, New Jersey, 08816, United States
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Azienda Ospedaliero - Universitaria Senese
Siena, 53100, Italy
-
Azienda Ospedaliero - Universitaria di Bologna - IRCCS
Bologna, 40138, Italy
-
Azienda Ospedaliero-Universitaria di Modena - Policlinico
Modena, 41124, Italy
-
Blacktown Hospital
Westmead, New South Wales, 2145, Australia
-
CHU UCL Namur - Sainte-Elisabeth
Namur, 5000, Belgium
-
Cairns Hospital
Cairns, Queensland, 4870, Australia
-
Centre Georges François Leclerc
Dijon, 21079, France
-
Centre Hospitalizer De L'Ardenne
Libramont-Chevigny, 6800, Belgium
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre de Lutte Contre le Cancer (CLCC) - Centre Antoine Lacassagne (CAL) - Site Est
Nice, 6189, France
-
Centro Hospitalar Universitario do Porto
Porto, 4050-011, Portugal
-
Centro Hospitalar do Algarve
Faro, 8000-366, Portugal
-
Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy
Bydgoszcz, 85-796, Poland
-
Charite University Medicine
Berlin, 10177, Germany
-
City of Hope
Duarte, California, 91010, United States
-
Civils de Lyon-Centre Hopitalier Lyon Sud
Pierre-Bénite, 69310, France
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Fondazione IRCCS Istituto Nazionale Tumori Milano
Milan, 20133, Italy
-
Hopital Foch
Suresnes, 92151, France
-
Hopital Pitie-Salpetriere
Paris, 75013, France
-
Hopital de la Timone
Marseille, 13005, France
-
Hospital CUF Descobertas
Lisbon, 1998-018, Portugal
-
Hospital Clínico Universitario de Valencia
Valencia, Spain
-
Hospital De La Santa Creu I Sant Pau
Barcelona, 8041, Spain
-
Hospital General Universitario Gregorio Maranon
Madrid, 28007, Spain
-
Hospital Regional Universitario de Malaga
Málaga, 29010, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitari i Politecnic La Fe
Valencia, 46026, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Virgen Macarena
Seville, 41009, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Hospital Universitario de Jaen
Jaén, 23007, Spain
-
Hospital de Braga
Braga, 4710-243, Portugal
-
Hospital del Mar
Barcelona, 8003, Spain
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital
New York, New York, 10029, United States
-
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Institut Bergonie
Bordeaux, 33000, France
-
Institut Curie
Paris, 75005, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Instituto Portugues de Oncologia Do Porto Francisco Gentil,E.P.E.
Porto, 4200-072, Portugal
-
Ironwood Cancer and Research Center
Chandler, Arizona, 85224, United States
-
Kath. Marienkrankenhaus gGmbH
Hamburg, 22087, Germany
-
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson Cancer Center
Madrid, 28033, Spain
-
Macquarie University
Macquarie Park, New South Wales, 2109, Australia
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Memorial Healthcare System
Hollywood, Florida, 33021, United States
-
Musgrove Park Hospital
Taunton, TA1 5DA, United Kingdom
-
Narodowy Instytut Onkologii im. M. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Glowy i Szyi
Warsaw, 2781, Poland
-
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Panstwowy Instytut Badawczy, Oddzial x Gliwicach
Gliwice, 44-102, Poland
-
New York Cancer and Blood Specialists
Port Jefferson Station, New York, 11776, United States
-
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
Ocala Oncology Center
Ocala, Florida, 34471, United States
-
Ospedale San Luca Luca
Lucca, 55100, Italy
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Princess Margaret Hospital
Lai Chi Kok, Hong Kong
-
Providence Medical Foundation
Santa Rosa, California, 95403, United States
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Royal Marsden NHS Foundation Trust, Royal Marsden - Sutton
London, SM2 5PT, United Kingdom
-
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122, United States
-
St. Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
Stanford Cancer Institute
Palo Alto, California, 94305, United States
-
Technische Universitat Munchen (TUM) - Klinikum Rechts der Isar
Munich, 81675, Germany
-
Torrance Memorial Physician Network - Cancer Care Associates
Redondo Beach, California, 90277, United States
-
UCLA Hematology/Oncology
Los Angeles, California, 90095, United States
-
UZ Antwerpen
Edegem, 2650, Belgium
-
Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA
Matosinhos Municipality, 4464-513, Portugal
-
Universitaire Ziekenhuis Leuven
Leuven, 3000, Belgium
-
Universitatsmedizin Gottingen
GÃttingen, 37075, Germany
-
University Center and Blood Center,LLC.
Athens, Georgia, 30607, United States
-
University of the Sunshine Coast
Sippy Downs, Queensland, 4556, Australia
-
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III
Bonn, 53127, Germany
-
Universitäres Krebszentrum Leipzig
Leipzig, 4103, Germany
-
Virginia Piper Cancer Center (Alliant Health
Minneapolis, Minnesota, 55407, United States
-
Washington University of Medicine- Siteman Cancer Center
St Louis, Missouri, 63110, United States
-
Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie, Oddzial Onkologii Klinicznej i Immunookologii z Poddoddzialem Dziennym i Izba Przyjec
Poznan, 61-866, Poland
-
Wojewodzki Szpital Specjalistyczny w Siedlcach
Siedlce, 08-110, Poland
-
ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg
Antwerp, 2020, Belgium
Conditions
Explore the condition pages connected to this study.